Cargando…

An economic analysis of poliovirus risk management policy options for 2013–2052

BACKGROUND: The Global Polio Eradication Initiative plans for coordinated cessation of oral poliovirus vaccine (OPV) after interrupting all wild poliovirus (WPV) transmission, but many questions remain related to long-term poliovirus risk management policies. METHODS: We used an integrated dynamic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duintjer Tebbens, Radboud J., Pallansch, Mark A., Cochi, Stephen L., Wassilak, Steven G.F., Thompson, Kimberly M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582932/ https://www.ncbi.nlm.nih.gov/pubmed/26404632 http://dx.doi.org/10.1186/s12879-015-1112-8

Ejemplares similares

Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination
por: Kalkowska, Dominika A, et al.
Publicado: (2015)

The potential impact of expanding target age groups for polio immunization campaigns
por: Duintjer Tebbens, Radboud J, et al.
Publicado: (2014)

Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
por: Thompson, Kimberly M., et al.
Publicado: (2015)

Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
por: Thompson, Kimberly M., et al.
Publicado: (2015)

Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2017)

How should we prepare for an outbreak of reintroduced live polioviruses?
por: Thompson, Kimberly M, et al.
Publicado: (2017)

Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2018)

Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2017)

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes
por: Thompson, Kimberly M., et al.
Publicado: (2017)

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2018)

Another look at silent circulation of poliovirus in small populations
por: Kalkowska, Dominika A., et al.
Publicado: (2018)

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Global certification of wild poliovirus eradication: insights from modelling hard-to-reach subpopulations and confidence about the absence of transmission
por: Duintjer Tebbens, Radboud J, et al.
Publicado: (2019)

Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy
por: DUINTJER TEBBENS, R. J., et al.
Publicado: (2017)

Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis
por: Duintjer Tebbens, Radboud J, et al.
Publicado: (2019)

Outbreak response strategies with type 2-containing oral poliovirus vaccines ()
por: Kalkowska, Dominika A., et al.
Publicado: (2023)

Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission
por: Thompson, Kimberly M., et al.
Publicado: (2017)

The impact of disruptions caused by the COVID-19 pandemic on global polio eradication()
por: Kalkowska, Dominika A., et al.
Publicado: (2023)

Possible Eradication of Wild Poliovirus Type 3 — Worldwide, 2012
por: Kew, Olen M., et al.
Publicado: (2014)

Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation
por: Kalkowska, Dominika A, et al.
Publicado: (2023)

Update on Vaccine-Derived Polioviruses — Worldwide, July 2012–December 2013
por: Diop, Ousmane M., et al.
Publicado: (2014)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2018–June 2019
por: Jorba, Jaume, et al.
Publicado: (2019)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2016–June 2017
por: Jorba, Jaume, et al.
Publicado: (2017)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018
por: Jorba, Jaume, et al.
Publicado: (2018)

Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States
por: Marin, Mona, et al.
Publicado: (2017)

Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal()
por: Harutyunyan, Vachagan, et al.
Publicado: (2023)

Progress Toward Poliovirus Containment Implementation — Worldwide, 2019–2020
por: Moffett, Daphne B., et al.
Publicado: (2020)

Tracking Progress Toward Polio Eradication — Worldwide, 2013–2014
por: Porter, Kimberly A., et al.
Publicado: (2015)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021
por: Alleman, Mary M., et al.
Publicado: (2021)

Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population
por: Wassilak, Steven, et al.
Publicado: (2011)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020
por: Alleman, Mary M., et al.
Publicado: (2020)

The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan – 2011–2013
por: Cowger, Tori L., et al.
Publicado: (2017)

Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters
por: Kalkowska, D. A., et al.
Publicado: (2019)

Interim CDC Guidance for Polio Vaccination for Travel to and from Countries Affected by Wild Poliovirus
por: Wallace, Gregory S., et al.
Publicado: (2014)

Progress Toward Polio Eradication — Worldwide, 2013–2014
por: Moturi, Edna K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4r2324cetfn6fhra37f4916s7t